Climate Takes is Carbon13's podcast where we ask climate entrepreneurs, innovators and funders for their takes on their industry and climate challenges, while also asking what it takes to solve the climate emergency.
Carbon13 is the Venture Builder for the climate emergency. Based in Cambridge, London and Berlin, we support and invest in entrepreneurs tackling challenges to Earth's Vital Systems.
Since 2021, we have worked with over 1000 entrepreneurs, invested in over 70 startups which collectively have a decarbonisation potential of 500 million tonnes per year by 2040.
Climate Takes is our chance to invite special guests from this community, and share the learnings, insights and determination needed to scale climate solutions.
All content for Climate Takes is the property of Carbon13 and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Climate Takes is Carbon13's podcast where we ask climate entrepreneurs, innovators and funders for their takes on their industry and climate challenges, while also asking what it takes to solve the climate emergency.
Carbon13 is the Venture Builder for the climate emergency. Based in Cambridge, London and Berlin, we support and invest in entrepreneurs tackling challenges to Earth's Vital Systems.
Since 2021, we have worked with over 1000 entrepreneurs, invested in over 70 startups which collectively have a decarbonisation potential of 500 million tonnes per year by 2040.
Climate Takes is our chance to invite special guests from this community, and share the learnings, insights and determination needed to scale climate solutions.
Welcome to Carbon13's podcast "Climate Takes" where we ask special guests for their "takes" on their industry and climate challenge, as well as setting a call to action, asking what will it take to solve the climate emergency?
In this episode we're looking at synthetic biology, which sounds simple: it means engineering organisms to have new functions. But it's not a peripheral technology, it is predicted to be one of the 21st century's most disruptive technologies on a scale similar to AI. The current bioeconomy is already $4 trillion, and it's projected to hit $30 trillion by 2050.
But like AI, synbio has a lot of challenges, and there's a graveyard of startups in this sector. In this episode, Tim Corcoran and Manuel Rios of Deep Blue Biotech give us their takes on why startups have struggled, and yet, why synbio could be so significant for human progress.
Subscribe to Climate Takes to find more content on founding and investing in climatetech, with Takes on green chemicals, innovative materials, AI, and hard won lessons in climate entrepreneurship.
Climate Takes
Climate Takes is Carbon13's podcast where we ask climate entrepreneurs, innovators and funders for their takes on their industry and climate challenges, while also asking what it takes to solve the climate emergency.
Carbon13 is the Venture Builder for the climate emergency. Based in Cambridge, London and Berlin, we support and invest in entrepreneurs tackling challenges to Earth's Vital Systems.
Since 2021, we have worked with over 1000 entrepreneurs, invested in over 70 startups which collectively have a decarbonisation potential of 500 million tonnes per year by 2040.
Climate Takes is our chance to invite special guests from this community, and share the learnings, insights and determination needed to scale climate solutions.
